Screening and detection of PCa are still mainly based on serum prostate specific antigen (PSA), which is more sensitive than specific for PCa [2] and produces a significant portion of false negative [3] and false positive [4] results. This evidence concerns the gene KLK3 and posterior cortical atrophy.